Cargando…
Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
BACKGROUND: The sixth leading class of cancer worldwide is head and neck cancer, which typically arise within the squamous epithelium of the oral mucosa. Human head and neck squamous cell carcinoma (HNSCC) is known to be difficult to treat and has only a 50% five-year survival rate. With HNSCC, nove...
Autores principales: | Hall, Bradford, Nakashima, Hideyuki, Sun, Zhi-Jun, Sato, Yuki, Bian, Yansong, Husain, Syed R, Puri, Raj K, Kulkarni, Ashok B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598213/ https://www.ncbi.nlm.nih.gov/pubmed/23421960 http://dx.doi.org/10.1186/1479-5876-11-45 |
Ejemplares similares
-
Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
por: Nakashima, Hideyuki, et al.
Publicado: (2010) -
Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma
por: Han, Jing, et al.
Publicado: (2014) -
Inhibition of mTOR Reduces Anal Carcinogenesis in Transgenic Mouse Model
por: Sun, Zhi-Jun, et al.
Publicado: (2013) -
Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy
por: Sato, Yuki, et al.
Publicado: (2014) -
The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway
por: Xu, Qiaoshi, et al.
Publicado: (2020)